INTS vs PSX
Intensity Therapeutics, Inc. Common stock (INTS) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported PSX revenue for 2024-12-31 was $143.15B. Net income was $2.17B. Revenue was down 2.9% from 2023-12-31 to 2024-12-31. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
INTS currently screens at market cap $7.7M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the INTS and PSX stock pages for the full models.
Not investment advice.